User menu

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

Bibliographic reference Sandercock, Peter ; Lindley, Richard ; Wardlaw, Joanna ; Dennis, Martin ; Innes, Karen ; et. al. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. In: Trials, Vol. 12, p. 252 [1-9] (2011)
Permanent URL
  1. Sandercock Peter, , Lindley Richard, Wardlaw Joanna, Dennis Martin, Lewis Steff, Venables Graham, Kobayashi Adam, Czlonkowska Anna, Berge Eivind, Slot Karsten Bruins, Murray Veronica, Peeters Andre, Hankey Graeme, Matz Karl, Brainin Michael, Ricci Stefano, Celani Maria Grazia, Righetti Enrico, Cantisani Teresa, Gubitz Gord, Phillips Steve, Arauz Antonio, Prasad Kameshwar, Correia Manuel, Lyrer Phillippe, The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke, 10.1186/1745-6215-9-37
  2. Warlow Charles, MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis, 10.1016/0140-6736(91)92916-p
  3. Peto R., Baigent C., Trials: the next 50 years, 10.1136/bmj.317.7167.1170
  4. Collins Rory, MacMahon Stephen, Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials, 10.1016/s0140-6736(00)03651-5
  5. Ware James H., Hamel Mary Beth, Pragmatic Trials — Guides to Better Patient Care?, 10.1056/nejmp1103502
  6. McMahon Alex D., Study control, violators, inclusion criteria and defining explanatory and pragmatic trials, 10.1002/sim.1120
  7. Hacke Werner, Kaste Markku, Bluhmki Erich, Brozman Miroslav, Dávalos Antoni, Guidetti Donata, Larrue Vincent, Lees Kennedy R., Medeghri Zakaria, Machnig Thomas, Schneider Dietmar, von Kummer Rüdiger, Wahlgren Nils, Toni Danilo, Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, 10.1056/nejmoa0804656
  8. Kent David M, Rothwell Peter M, Ioannidis John PA, Altman Doug G, Hayward Rodney A, Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal, 10.1186/1745-6215-11-85
  9. , Can We Improve the Statistical Analysis of Stroke Trials?: Statistical Reanalysis of Functional Outcomes in Stroke Trials * OAST Supplemental Appendix I: Statistical Tests Compared (see Table I) * OAST Supplemental Appendix II: Supplementary Analyses * OAST Supplemental Appendix III: Trial Data (see Tables II and III) * OAST Supplemental Appendix IV: Results (see Table IV), 10.1161/strokeaha.106.474080
  10. Saver J. L., Novel End Point Analytic Techniques and Interpreting Shifts Across the Entire Range of Outcome Scales in Acute Stroke Trials, 10.1161/strokeaha.107.488536
  11. Hacke Werner, Kaste Markku, Fieschi Cesare, von Kummer Rüdiger, Davalos Antoni, Meier Dieter, Larrue Vincent, Bluhmki Erich, Davis Stephen, Donnan Geoffrey, Schneider Dietmar, Diez-Tejedor Exuperio, Trouillas Paul, Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II), 10.1016/s0140-6736(98)08020-9
  12. Sanossian Nerses, Ovbiagele Bruce, Prevention and management of stroke in very elderly patients, 10.1016/s1474-4422(09)70259-5
  13. Wardlaw JM, Murray V, Berge E, del Zoppo GJ: Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009, CD000213-4
  14. Konig I. R., Ziegler A., Bluhmki E., Hacke W., Bath P. M.W., Sacco R. L., Diener H. C., Weimar C., , Predicting Long-Term Outcome After Acute Ischemic Stroke: A Simple Index Works in Patients From Controlled Clinical Trials, 10.1161/strokeaha.107.505867